Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction
NCT ID: NCT03904329
Last Updated: 2022-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2020-10-01
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity Phenotypes and Its Relation to Cardiovascular Diseases
NCT06092021
Characterization of Bile Acid Pathway in Obesity
NCT03341052
Prognostic Value of Adipokine Levels of Patients With Chronic Heart Failure
NCT02812797
Effect of Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone Responses in Obese and Healthy Weight Subjects
NCT03860623
The Weight of Cardiovascular Disease
NCT06053645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese Patients with non valvular AF
Obese Patients with non valvular AF using oral anti coagulants
Oral Anticoagulant
Oral tablets of anti coagulations either warfare or NOACs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Anticoagulant
Oral tablets of anti coagulations either warfare or NOACs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients on oral anticoagulant
Exclusion Criteria
* Mental illness
* History of cerebrovascular stroke
* history of bleeding tendency
* history of Chronic renal failure
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christena amir
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kristen amir
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kristen Amir
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Assuit35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.